Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fabrizio Vernieri

Showing results (161-170 of 188) with videos related to

Pageof 19
Sort By:
Frontiers in Neurology|April 16, 2026
Rapid effectiveness of eptinezumab to treat ongoing migraine attacks: preliminary data from an Italian multicenter real-world experience (the BE-FREE study)Luisa Fofi, Claudia Altamura, Marilena Marcosano, et al.
European Journal of Neurology|September 13, 2022
Maintenance of response and predictive factors of 1-year GalcanezumAb treatment in real-life migraine patients in Italy: The multicenter prospective cohort GARLIT studyFabrizio Vernieri, Nicoletta Brunelli, Marilena Marcosano, et al.
Neurobiology of Aging|August 3, 2013
Cortical sources of resting state electroencephalographic alpha rhythms deteriorate across time in subjects with amnesic mild cognitive impairmentClaudio Babiloni, Claudio Del Percio, Roberta Lizio, et al.
Journal of the Neurological Sciences|March 21, 2013
Diffusion-weighted lesions after carotid artery stenting are associated with cognitive impairmentPaola Maggio, Claudia Altamura, Doriana Landi, et al.
Journal of Neurology|July 19, 2023
Retreating migraine patients in the second year with monoclonal antibodies anti-CGRP pathway: the multicenter prospective cohort RE-DO studyFabrizio Vernieri, Nicoletta Brunelli, Simona Guerzoni, et al.
Frontiers in Human Neuroscience|May 7, 2021
Pathophysiological Bases of Comorbidity in MigraineClaudia Altamura, Ilenia Corbelli, Marina de Tommaso, et al.
The Journal of Headache and Pain|November 1, 2022
Predictors of response to anti-CGRP monoclonal antibodies: a 24-week, multicenter, prospective study on 864 migraine patientsPiero Barbanti, Gabriella Egeo, Cinzia Aurilia, et al.
The Journal of Headache and Pain|May 4, 2021
Galcanezumab for the prevention of high frequency episodic and chronic migraine in real life in Italy: a multicenter prospective cohort study (the GARLIT study)Fabrizio Vernieri, Claudia Altamura, Nicoletta Brunelli, et al.
Journal of Alzheimer'S Disease : JAD|January 24, 2013
Cortical sources of resting state EEG rhythms are sensitive to the progression of early stage Alzheimer's diseaseClaudio Babiloni, Roberta Lizio, Claudio Del Percio, et al.
Journal of Neurology|June 28, 2022
Conversion from chronic to episodic migraine in patients treated with galcanezumab in real life in Italy: the 12-month observational, longitudinal, cohort multicenter GARLIT experienceClaudia Altamura, Nicoletta Brunelli, Marilena Marcosano, et al.
Pageof 19

Showing results (161-170 of 188) with videos related to

Sort By:
Pageof 19
Frontiers in Neurology|April 16, 2026
Rapid effectiveness of eptinezumab to treat ongoing migraine attacks: preliminary data from an Italian multicenter real-world experience (the BE-FREE study)Luisa Fofi, Claudia Altamura, Marilena Marcosano, et al.
European Journal of Neurology|September 13, 2022
Maintenance of response and predictive factors of 1-year GalcanezumAb treatment in real-life migraine patients in Italy: The multicenter prospective cohort GARLIT studyFabrizio Vernieri, Nicoletta Brunelli, Marilena Marcosano, et al.
Neurobiology of Aging|August 3, 2013
Cortical sources of resting state electroencephalographic alpha rhythms deteriorate across time in subjects with amnesic mild cognitive impairmentClaudio Babiloni, Claudio Del Percio, Roberta Lizio, et al.
Journal of the Neurological Sciences|March 21, 2013
Diffusion-weighted lesions after carotid artery stenting are associated with cognitive impairmentPaola Maggio, Claudia Altamura, Doriana Landi, et al.
Journal of Neurology|July 19, 2023
Retreating migraine patients in the second year with monoclonal antibodies anti-CGRP pathway: the multicenter prospective cohort RE-DO studyFabrizio Vernieri, Nicoletta Brunelli, Simona Guerzoni, et al.
Frontiers in Human Neuroscience|May 7, 2021
Pathophysiological Bases of Comorbidity in MigraineClaudia Altamura, Ilenia Corbelli, Marina de Tommaso, et al.
The Journal of Headache and Pain|November 1, 2022
Predictors of response to anti-CGRP monoclonal antibodies: a 24-week, multicenter, prospective study on 864 migraine patientsPiero Barbanti, Gabriella Egeo, Cinzia Aurilia, et al.
The Journal of Headache and Pain|May 4, 2021
Galcanezumab for the prevention of high frequency episodic and chronic migraine in real life in Italy: a multicenter prospective cohort study (the GARLIT study)Fabrizio Vernieri, Claudia Altamura, Nicoletta Brunelli, et al.
Journal of Alzheimer'S Disease : JAD|January 24, 2013
Cortical sources of resting state EEG rhythms are sensitive to the progression of early stage Alzheimer's diseaseClaudio Babiloni, Roberta Lizio, Claudio Del Percio, et al.
Journal of Neurology|June 28, 2022
Conversion from chronic to episodic migraine in patients treated with galcanezumab in real life in Italy: the 12-month observational, longitudinal, cohort multicenter GARLIT experienceClaudia Altamura, Nicoletta Brunelli, Marilena Marcosano, et al.
Pageof 19